{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:56Z","timestamp":1792784096189,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30873173"],"award-info":[{"award-number":["30873173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81001410"],"award-info":[{"award-number":["81001410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundamental Research Funds for the Central Universities, China"},{"name":"China\u2010Japan Scientific Cooperation Program","award":["81011140077"],"award-info":[{"award-number":["81011140077"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jconrel.2012.07.034","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T21:00:49Z","timestamp":1343941249000},"page":"464-473","source":"Crossref","is-referenced-by-count":58,"title":["Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases"],"prefix":"10.1016","volume":"162","author":[{"given":"Bing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/rme.10.72","article-title":"Mesenchymal stem cells for the treatment of neurodegenerative disease","volume":"5","author":"Joyce","year":"2010","journal-title":"Regen. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/exnr.2001.7853","article-title":"Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats","volume":"174","author":"Zhao","year":"2002","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/147323001103900216","article-title":"Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia","volume":"39","author":"Zhu","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jconrel.2012.07.034_bb0020","unstructured":"K.A. Chang, J.A. Kim, S. Kim, Y. Joo, K.Y. Shin, H.S. Kim, Y.H. Suh, Therapeutic potentials of neural stem cells treated with fluoxetine in Alzheimer's disease, Neurochem. Int. (in press), http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0197018612001192."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3171\/jns.2005.103.2.0304","article-title":"Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain","volume":"103","author":"Takagi","year":"2005","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.jconrel.2012.07.034_bb0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/08830185.2010.498931","article-title":"Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications","volume":"29","author":"Deak","year":"2010","journal-title":"Int. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2012.07.034_bb0035","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jgm.452","article-title":"Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome","volume":"5","author":"Chapel","year":"2003","journal-title":"J. Gene Med."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yjmcc.2008.01.004","article-title":"Homing and engraftment of progenitor cells: a prerequisite for cell therapy","volume":"45","author":"Chavakis","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.jconrel.2012.07.034_bb0045","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","article-title":"Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction","volume":"112","author":"Kraitchman","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0050","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.biomaterials.2011.12.009","article-title":"Monitoring transplanted adipose tissue-derived stem cells combined with heparin in the liver by fluorescence imaging using quantum dots","volume":"33","author":"Yukawa","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jconrel.2012.07.034_bb0060","doi-asserted-by":"crossref","first-page":"342968","DOI":"10.1155\/2012\/342968","article-title":"Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy","volume":"2012","author":"Kang","year":"2012","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1634\/stemcells.2006-0243","article-title":"In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models","volume":"25","author":"Meyerrose","year":"2007","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/stem.150443","article-title":"Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model","volume":"15","author":"Dao","year":"1997","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jnr.10691","article-title":"Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat","volume":"73","author":"Chen","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.20126","article-title":"Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells","volume":"49","author":"Li","year":"2005","journal-title":"Glia"},{"issue":"12","key":"10.1016\/j.jconrel.2012.07.034_bb0085","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1002\/art.11365","article-title":"Stem cell therapy in a caprine model of osteoarthritis","volume":"48","author":"Murphy","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis","volume":"198","author":"Crigler","year":"2006","journal-title":"Exp. Neurol."},{"issue":"14","key":"10.1016\/j.jconrel.2012.07.034_bb0095","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/jnr.22146","article-title":"Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth","volume":"87","author":"Aizman","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1634\/stemcells.2007-1047","article-title":"Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1","volume":"27","author":"Kim","year":"2009","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2008.04.106","article-title":"Stem cell-based cell replacement strategies for the central nervous system","volume":"456","author":"Sharp","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"issue":"50","key":"10.1016\/j.jconrel.2012.07.034_bb0115","doi-asserted-by":"crossref","first-page":"18171","DOI":"10.1073\/pnas.0508945102","article-title":"Human stem\/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice","volume":"102","author":"Munoz","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.59.4.514","article-title":"Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery","volume":"59","author":"Li","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2012.07.034_bb0130","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2741\/e449","article-title":"Genetically modified stem cells for the treatment of neurological diseases","volume":"4","author":"Mitrecic","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0304-3940(02)00981-3","article-title":"Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins","volume":"333","author":"Lee","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1789.2006.00688.x","article-title":"Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease","volume":"26","author":"Kim","year":"2006","journal-title":"Neuropathology"},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0145","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model","volume":"99","author":"Bjorklund","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2008.12.001","article-title":"Effects of engrafted neural stem cells in Alzheimer's disease rats","volume":"450","author":"Xuan","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(03)00174-5","article-title":"Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia","volume":"343","author":"Chu","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2004.04.038","article-title":"Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia","volume":"1016","author":"Chu","year":"2004","journal-title":"Brain Res."},{"issue":"16","key":"10.1016\/j.jconrel.2012.07.034_bb0165","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1158\/1078-0432.CCR-05-0371","article-title":"PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model","volume":"11","author":"Kim","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"11\u201312","key":"10.1016\/j.jconrel.2012.07.034_bb0170","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1111\/j.1582-4934.2009.00857.x","article-title":"Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine","volume":"13","author":"Satija","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ana.22487","article-title":"Stem cell technology for neurodegenerative diseases","volume":"70","author":"Lunn","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2008.05.006","article-title":"Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke","volume":"16","author":"Dharmasaroja","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jconrel.2012.07.034_bb0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1517\/17425247.2011.566267","article-title":"Intranasal delivery of stem cells to the brain","volume":"8","author":"Jiang","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2012.07.034_bb0190","doi-asserted-by":"crossref","first-page":"SIII23","DOI":"10.1016\/S0140-6736(98)90091-5","article-title":"Issues and answers in stroke care","volume":"352","author":"van Gijn","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jconrel.2012.07.034_bb0195","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/jcbfm.2009.62","article-title":"Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke","volume":"29","author":"Hayase","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0200","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00001756-199904260-00025","article-title":"Targeting of marrow-derived astrocytes to the ischemic brain","volume":"10","author":"Eglitis","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.jconrel.2012.07.034_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2010.10.063","article-title":"Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats","volume":"1367","author":"Bao","year":"2011","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.jconrel.2012.07.034_bb0210","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00004647-200009000-00006","article-title":"Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice","volume":"20","author":"Li","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymthe.2003.10.012","article-title":"BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model","volume":"9","author":"Kurozumi","year":"2004","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2012.07.034_bb0220","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1161\/01.STR.0000190006.88896.d3","article-title":"Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats","volume":"36","author":"Ikeda","year":"2005","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jconrel.2012.07.034_bb0225","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0028-3908(00)00006-X","article-title":"Intracerebral transplantation of bone marrow with BDNF after MCAo in rat","volume":"39","author":"Chen","year":"2000","journal-title":"Neuropharmacology"},{"issue":"15\u201316","key":"10.1016\/j.jconrel.2012.07.034_bb0230","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1089\/ten.tea.2010.0585","article-title":"Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats","volume":"17","author":"Matsuse","year":"2011","journal-title":"Tissue Eng. Part A"},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1474-4422(02)00040-6","article-title":"Treatment of neural injury with marrow stromal cells","volume":"1","author":"Chopp","year":"2002","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.jconrel.2012.07.034_bb0240","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1073\/pnas.94.8.4080","article-title":"Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice","volume":"94","author":"Eglitis","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.jconrel.2012.07.034_bb0245","doi-asserted-by":"crossref","first-page":"10711","DOI":"10.1073\/pnas.96.19.10711","article-title":"Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains","volume":"96","author":"Kopen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0250","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.95.7.3908","article-title":"Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats\u2013similarities to astrocyte grafts","volume":"95","author":"Azizi","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1440-1789.2002.00450.x","article-title":"Ischemic rat brain extracts induce human marrow stromal cell growth factor production","volume":"22","author":"Chen","year":"2002","journal-title":"Neuropathology"},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0260","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"Chen","year":"2003","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0265","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"issue":"5580","key":"10.1016\/j.jconrel.2012.07.034_bb0270","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2010.06.045","article-title":"The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease","volume":"481","author":"Lee","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2008.11.059","article-title":"Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model","volume":"450","author":"Lee","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/stem.277","article-title":"Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0290","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1474-4422(03)00411-3","article-title":"Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics","volume":"2","author":"Blum","year":"2003","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0295","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/00207450390207759","article-title":"Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes","volume":"113","author":"Lescaudron","year":"2003","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"10.1016\/j.jconrel.2012.07.034_bb0300","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1179\/174313208X327955","article-title":"Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration","volume":"30","author":"Amin","year":"2008","journal-title":"Neurol. Res."},{"issue":"35","key":"10.1016\/j.jconrel.2012.07.034_bb0305","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","article-title":"Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease","volume":"214","author":"Dey","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2012.07.034_bb0315","first-page":"S16","article-title":"Functional models of Parkinson's disease: a valuable tool in the development of novel therapies","volume":"64","author":"Jenner","year":"2008","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresprot.2005.03.002","article-title":"Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease","volume":"15","author":"Lu","year":"2005","journal-title":"Brain Res. Brain Res. Protoc."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10072-010-0385-3","article-title":"The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model","volume":"32","author":"Shi","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jconrel.2012.07.034_bb0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2010.08.040","article-title":"Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain","volume":"1359","author":"Moloney","year":"2010","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0340","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00177425","article-title":"Intrinsic brainstem tumors in childhood: surgical indications","volume":"6","author":"Epstein","year":"1988","journal-title":"J. Neurooncol."},{"issue":"11","key":"10.1016\/j.jconrel.2012.07.034_bb0345","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/1097-0142(19800601)45:11<2787::AID-CNCR2820451113>3.0.CO;2-V","article-title":"Pediatric brain stem gliomas","volume":"45","author":"Littman","year":"1980","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0350","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1349-7006.2005.00032.x","article-title":"Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy","volume":"96","author":"Hamada","year":"2005","journal-title":"Cancer Sci."},{"issue":"23","key":"10.1016\/j.jconrel.2012.07.034_bb0355","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","article-title":"Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas","volume":"97","author":"Aboody","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.jconrel.2012.07.034_bb0360","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0365","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: nature, biology, and potential applications","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"issue":"14","key":"10.1016\/j.jconrel.2012.07.034_bb0370","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3302276","article-title":"Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model","volume":"11","author":"Nakamura","year":"2004","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0375","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cellbi.2008.07.023","article-title":"Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats","volume":"33","author":"Xu","year":"2009","journal-title":"Cell Biol. Int."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0380","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1227\/01.NEU.0000345646.85472.EA","article-title":"Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model","volume":"64","author":"Hong","year":"2009","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/neuonc\/noq147","article-title":"Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma","volume":"13","author":"Choi","year":"2011","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2012.07.034_bb0390","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/ijc.25383","article-title":"The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase","volume":"127","author":"Chang","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0395","first-page":"1265","article-title":"Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy","volume":"35","author":"Amano","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0400","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2176\/nmc.50.545","article-title":"Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells","volume":"50","author":"Mori","year":"2010","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"26","key":"10.1016\/j.jconrel.2012.07.034_bb0405","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0410","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1634\/stemcells.2006-0257","article-title":"Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells","volume":"25","author":"Menon","year":"2007","journal-title":"Stem Cells"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2012.07.034_bb0415","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2005.10.031","article-title":"Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct?\u2013a double labeling study","volume":"1065","author":"Yano","year":"2005","journal-title":"Brain Res."},{"issue":"5403","key":"10.1016\/j.jconrel.2012.07.034_bb0420","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.283.5403.845","article-title":"Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4","volume":"283","author":"Peled","year":"1999","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jconrel.2012.07.034_bb0425","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.exphem.2006.04.002","article-title":"Mutual, reciprocal SDF-1\/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD\/SCID chimeric mice","volume":"34","author":"Dar","year":"2006","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0430","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3892\/or_00000796","article-title":"Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro","volume":"23","author":"Xu","year":"2010","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jnen\/63.1.84","article-title":"SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury","volume":"63","author":"Hill","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jconrel.2012.07.034_bb0440","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2007.08.091","article-title":"Role of SDF-1\/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct","volume":"1183","author":"Shichinohe","year":"2007","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0445","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbrc.2011.03.093","article-title":"CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas","volume":"407","author":"Kim","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0450","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10245330290028588","article-title":"MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture","volume":"7","author":"Wang","year":"2002","journal-title":"Hematology"},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0455","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0301-472X(02)00829-9","article-title":"Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture","volume":"30","author":"Wang","year":"2002","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0460","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/stem.50","article-title":"Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma","volume":"27","author":"Ho","year":"2009","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0465","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1227\/NEU.0b013e318232dedd","article-title":"Rat multipotent mesenchymal stromal cells lack long-distance tropism to three different rat glioma models","volume":"70","author":"Bexell","year":"2011","journal-title":"Neurosurgery"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2012.07.034_bb0470","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2012.01.001","article-title":"Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke","volume":"316","author":"Yu","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2012.07.034_bb0475","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.cgt.7700827","article-title":"Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors","volume":"12","author":"Sato","year":"2005","journal-title":"Cancer Gene Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0480","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","article-title":"Viral vectors for gene transfer: a review of their use in the treatment of human diseases","volume":"60","author":"Walther","year":"2000","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0485","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2010.05.015","article-title":"Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy","volume":"147","author":"Hu","year":"2010","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0490","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2011.08.027","article-title":"Genetically-manipulated adult stem cells as therapeutic agents and gene delivery vehicle for wound repair and regeneration","volume":"157","author":"Peng","year":"2012","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0495","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1007548826495","article-title":"Cationic polymer based gene delivery systems","volume":"17","author":"De Smedt","year":"2000","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0500","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/0929867043456160","article-title":"Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level","volume":"11","author":"Ewert","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0505","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0958-1669(02)00294-X","article-title":"Non-viral gene delivery systems","volume":"13","author":"Davis","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2012.07.034_bb0510","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijpharm.2009.12.033","article-title":"Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity","volume":"387","author":"Gao","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i1.10","article-title":"Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting","volume":"18","author":"Vyas","year":"2001","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0520","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jgm.382","article-title":"Integrin targeting using RGD-PEI conjugates for in vitro gene transfer","volume":"5","author":"Kunath","year":"2003","journal-title":"J. Gene Med."},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0525","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.0000079161.56080.22","article-title":"Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells","volume":"108","author":"Nagaya","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2012.07.034_bb0530","article-title":"Preparation of biodegradable gelatin nanospheres with a narrow size distribution for carrier of cellular internalization of plasmid DNA","author":"Doi","year":"2011","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0535","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/17425247.2011.547934","article-title":"Cellular interactions of therapeutically delivered nanoparticles","volume":"8","author":"Kumari","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.jconrel.2012.07.034_bb0540","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/term.228","article-title":"Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface","volume":"4","author":"Balyasnikova","year":"2010","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0545","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11095-011-0390-0","article-title":"Effective gene delivery to mesenchymal stem cells based on the reverse transfection and three-dimensional cell culture system","volume":"28","author":"He","year":"2011","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2012.07.034_bb0550","first-page":"229","article-title":"Impregnation of plasmid DNA into three-dimensional PLGA scaffold enhances DNA expression of mesenchymal stem cells in vitro","volume":"67","author":"Miao","year":"2012","journal-title":"Pharmazie"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2012.07.034_bb0555","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2009.11.006","article-title":"Non-viral gene delivery carrier and its three-dimensional transfection system","volume":"386","author":"He","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2012.07.034_bb0560","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1021\/bc800345q","article-title":"Chemical engineering of mesenchymal stem cells to induce a cell rolling response","volume":"19","author":"Sarkar","year":"2008","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0565","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.164.2.705","article-title":"Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method","volume":"164","author":"Chen","year":"2000","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.jconrel.2012.07.034_bb0570","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.biomaterials.2009.03.038","article-title":"Targeting mesenchymal stem cells to activated endothelial cells","volume":"30","author":"Ko","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0575","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/1061186X.2011.622398","article-title":"Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell","volume":"20","author":"Kean","year":"2012","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0580","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jconrel.2012.07.034_bb0585","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.jconrel.2012.07.034_bb0590","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.critrevonc.2007.09.007","article-title":"Therapeutic pathways of adult stem cell repair","volume":"65","author":"Ting","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0595","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14712598.7.2.173","article-title":"Development of adult pluripotent stem cell therapies for ischemic injury and disease","volume":"7","author":"Mays","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"24","key":"10.1016\/j.jconrel.2012.07.034_bb0600","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.jconrel.2012.07.034_bb0605","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/187152809788462635","article-title":"Treatment of inflammatory diseases with mesenchymal stem cells","volume":"8","author":"Newman","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"7","key":"10.1016\/j.jconrel.2012.07.034_bb0610","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14712590902956615","article-title":"Overview of stem cell therapy for Crohn's disease","volume":"9","author":"Dryden","year":"2009","journal-title":"Expert. Opin. Biol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912006013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912006013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T03:51:16Z","timestamp":1643082676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912006013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0168365912006013"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.07.034","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}